ENZNEnzon Pharmaceuticals, Inc.

About Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals, Inc. (ENZN) is a Biotechnology company headquartered in Cranford, NJ, United States whose shares trade over-the-counter on the OTCQX tier.

Enzon Pharmaceuticals, Inc. is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value.

Products and services

Enzon is a pharmaceutical patent holder and licensor that intends to acquire profitable entities in order to utilize its net operating loss carryovers.

ENZN key facts

Ticker symbol

ENZN

Market tier

OTCQX

Sector

Healthcare

Industry

Biotechnology

Headquarters

Cranford, NJ, United States

Country of incorporation

US

Year of incorporation

1983

Employees

1

Estimated market cap

$7.02M (as of Apr 16, 2025)

Shares outstanding

74,214,603

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Enzon Pharmaceuticals, Inc. leadership

• Richard L. Feinstein — CEO

Explore more: Biotechnology stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with E